Otiprio: cost and payments to doctors
What Medicare Part D paid pharmacies for Otiprio, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Alk-abello, Inc?
Alk-abello, Inc reported the most payments naming Otiprio. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $113K
- Providers
- 2,014
- Transactions
- 4,070
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,014 providers the average total is $56, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Alk-abello, Inc | $107,361 | 94.7% |
| Otonomy, Inc. | $3,532 | 3.1% |
| Glenmark Therapeutics Inc. | $2,487 | 2.2% |
Other products from Alk-abello, Inc
The company that reported the most payments naming Otiprio also reports against these.
- Odactra$1,596,381
- Grastek$868,617
- Ragwitek$818,000
- NEFFY$229,251
- PRE-PEN$88,640
- Dust mite (D. farinae)$41,567
- TIMOTHY, STANDARDIZED$32,667
- STANDARDIZED MITE D. FARINAE$22,183
- ALTERNARIA TENUIS$21,662
- Timothy Grass (phleum pratense)$8,059